Spero Therapeutics, Inc. (SPRO) Reports Q3 Loss, Tops Revenue Estimates

Published on November 10, 2021

Spero Therapeutics, Inc. (SPRO) delivered earnings and revenue surprises of 0.00% and 2.13%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for...